Pivoting to Telehealth: Optimizing Technology for the Care of Postmenopausal Women


Gloria A. Bachmann, MD, MMS
Professor of Obstetrics and Gynecology and Medicine
Associate Dean for Women's Health
Director, Women's Health Institute (WHI)
Medical Director of the PROUD Gender Center of NJ
Rutgers Robert Wood Johnson Medical School
New Brunswick, NJ
Gloria A. Bachmann, MD, MMS

Dr. Gloria Bachmann is a national and internationally recognized physician who has moved health care to the next level in many areas that include women’s advocacy, menopause, perinatal issues, obstetrical safety, sexual health, LGBTQ+ wellness, diversity and inclusion initiatives, as well as One Health and gynecologic pain syndromes. She is Professor of Obstetrics and Gynecology, Associate Dean for Women’s Health, and the Director of the Women’s Health Institute at Rutgers Robert Wood Johnson Medical School. In addition, Dr. Bachmann is the Medical Director of the PROUD Gender Center of New Jersey (NJ) and in this role has a focus in promoting sports activity for LGBTQ+ individuals. She is also an appointed committee member on the NJ Women’s Commission on Reentry Services for those who have been imprisoned. Dr. Bachmann is a respected clinician, a valued mentor, a prolific researcher, and a sought-after educator. She has a long history of being the principal and co-principal investigator on several clinical trials, including being principal investigator on federally funded NIH protocols. Currently, she is SPOKE PI on the NIH multicenter trial EPPIC-Net (developing meaningful endpoints for pain clinical trials). Data derived from her participation in multiple research trials has added extensively to the literature and to many advances in medical care. Dr. Bachmann is a graduate of Rutgers University and the Perlman School of Medicine at the University of Pennsylvania.

Statement of Need

Despite the immense burden that symptoms of menopause create for women in mid-life, highly effective hormone therapy (HT) for menopausal symptoms is underutilized by the medical community. Recent publication of updated guidelines and position statements has led to an urgent need to educate clinicians about the role of HT in supporting symptomatic women through the transition of menopause and reducing the stigma around both the symptoms and their treatment. The COVID-19 pandemic has highlighted the value of telehealth, which is likely to outlast the pandemic. Many clinicians have limited training, experience, and confidence with this modality, creating a need for education on how best to provide postmenopausal care via telehealth.

This CME Outfitters BriefCase will utilize patient cases to illustrate how clinicians can optimize technology for the care of postmenopausal women, with special focus on current evidence-based guidance on the risks and benefits of HT and implementing best practices for telehealth consultations with postmenopausal patients.

Learning Objectives

At the end of this CME/CE activity, participants should be able to:

  • Apply current evidence-based guidance on benefits and risks of HT to counseling and treatment decisions for postmenopausal patients.
  • Implement best practices for telehealth consultations with postmenopausal patients.

The following learning objectives pertain only to those requesting CNE or CPE credit:

  • Explain current evidence-based guidance on benefits and risks of HT to counseling and treatment decisions for postmenopausal patients.
  • Describe best practices for telehealth consultations with postmenopausal patients.

Financial Support

Supported by an educational grant from Pfizer Inc.

Target Audience

OB/GYNs, urogynecologists, primary care physicians, PAs, nurse practitioners, and pharmacists

Credit Information

Physicians (ACCME) 1.0

CME Outfitters, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Pharmacists/Pharmacy Tech (ACPE) 1.0

This application-based activity is approved for 1.0 contact hour (0.10 CEUs) of continuing pharmacy credit.
Activity UAN: JA0007185-0000-21-139-H01-P


Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 medical knowledge MOC point in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Royal College MOC

Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.

MIPS Improvement Activity

Completion of this accredited CME activity meets the expectations of an Accredited Safety or Quality Improvement Program (IA_PSPA_28) for the Merit-based Incentive Payment Program (MIPS). Clinicians should submit their improvement activities by attestation via the CMS Quality Payment Program website.

Disclosure Declaration

It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and mitigated any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.

Dr. Bachmann has no disclosures to report.

Disclosures were obtained from the CME Outfitters, LLC staff: No disclosures to report.

  • Jeffrey Helfand, DO (peer reviewer)
  • Mae Ochoa, RPh (peer reviewer) has no disclosures to report.
  • Juana Hutchinson-Coles, MD, MBA (planning committee)
  • Rachel Speer, PhD (planning committee)
  • Susan Perry (planning committee)
  • Jan Perez (planning committee)
  • Sharon Tordoff (planning committee)


Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.

Additional Formats

Post-tests, credit request forms, and activity evaluations must be completed online (requires free account activation), and participants can print their certificate or statement of credit immediately (75% pass rate required). This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit our Privacy & Confidentiality page.


NOTE: Pharmacist CE Universal Activity Number, Enduring: JA0007185-0000-21-139-H01-P

Questions about this activity?

Call us at 877.CME.PROS (877.263.7767).


Pivoting to Telehealth: Optimizing Technology for the Care of Postmenopausal Women
Event Date: 05/25/2021